Arkolith/Insider Trading/BNTC/Form 4

Cowen Aaron

10% OwnerBenitec Biopharma Inc. (BNTC) · full profile →Form 4 · filed Mar 28, 2025
Net Buying
Open-Market Buys
$11.7M
Open-Market Sells
$0
Net Open-Market Flow
$11.7M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2025Buy(P)794K$13.00$10.3M8.8M
Mar 26, 2025Buy(P)106K$13.00$1.4M1.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899140-25-000479) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML